# Aprepitant

## EMEND 125mg

| 藥物代碼           | OEM125                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Prevention of acute & delayed nausea & vomiting associated with initial & repeat courses of highly & moderately emetogenic cancer chemotherapy.                                                                                                       |
| 副作用             | Hiccups, asthenia/fatigue, ALT increased, constipation, headache, anorexia.Central nervous system: Fatigue (?18%)Gastrointestinal: Nausea (6% to 13%), constipation (9% to 10%)Neuromuscular & skeletal: Weakness (?18%) Miscellaneous: Hiccups (11%) |
| 禁忌               | Concurrent administration with pimozide, terfenadine, astemizole, or cisapride.                                                                                                                                                                       |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                  |
| 用法用量           | Given as part of a 3-day regimen that includes a corticosteroid & a 5-HT3 antagonist. Recommended dose: 125 mg orally 1 hr prior to chemotherapy (day 1) & 80 mg once daily in the morning on days 2 & 3.                                             |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                          |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                          |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                              |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest low risk                                                                                                                                                                                                |
| 附帶說明           | N/A                                                                                                                                                                                                                                                   |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                  |
| 附帶說明           | N/A                                                                                                                                                                                                                                                   |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                   |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                   |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                   |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                   |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                   |
| 注意事項           | N/A                                                                                                                                                                                                                                                   |

